Literature DB >> 27153211

RAD51 variant proteins from human lung and kidney tumors exhibit DNA strand exchange defects.

Michelle C Silva1, Milagros D Morrical1, Katie E Bryan1, April M Averill2, Julie Dragon2, Jeffrey P Bond3, Scott W Morrical4.   

Abstract

In human cells, error-free repair of DNA double-strand breaks requires the DNA pairing and strand exchange activities of RAD51 recombinase. Activation of RAD51 recombination activities requires the assembly of RAD51 presynaptic filaments on the single-stranded DNA that forms at resected DSB ends. Mutations in proteins that control presynaptic filament assembly, such as BRCA2, and in RAD51 itself, are associated with human breast cancer. Here we describe the properties of two mutations in RAD51 protein that derive from human lung and kidney tumors, respectively. Sequence variants Q268P and Q272L both map to the DNA binding loop 2 (L2) region of RAD51, a motif that is involved in DNA binding and in the allosteric activation of ATP hydrolysis and DNA strand exchange activities. Both mutations alter the thermal stability, DNA binding, and ATPase properties of RAD51, however both variants retain intrinsic DNA strand exchange activity towards oligonucleotide substrates under optimized conditions. In contrast, both Q268P and Q272L variants exhibit drastically reduced DNA strand exchange activity in reaction mixtures containing long homologous ssDNA and dsDNA substrates and human RPA protein. Mixtures of wild-type and variant proteins also exhibit reduced DNA strand exchange activity, suggesting that heterozygous mutations could negatively affect DNA recombination and repair processes in vivo. Together, the findings of this study suggest that hypomorphic missense mutations in RAD51 protein could be drivers of genomic instability in cancer cells, and thereby contribute to the etiology of metastatic disease.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Homology-directed repair; Presynaptic filament; RAD51; Recombination; Variant

Mesh:

Substances:

Year:  2016        PMID: 27153211      PMCID: PMC4884548          DOI: 10.1016/j.dnarep.2016.02.008

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  41 in total

1.  Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer.

Authors:  H Maacke; S Opitz; K Jost; W Hamdorf; W Henning; S Krüger; A C Feller; A Lopens; K Diedrich; E Schwinger; H W Stürzbecher
Journal:  Int J Cancer       Date:  2000-12-15       Impact factor: 7.396

2.  ATP-mediated conformational changes in the RecA filament.

Authors:  Margaret S VanLoock; Xiong Yu; Shixin Yang; Alex L Lai; Claudia Low; Michael J Campbell; Edward H Egelman
Journal:  Structure       Date:  2003-02       Impact factor: 5.006

3.  Identification of Rad51 alteration in patients with bilateral breast cancer.

Authors:  M Kato; K Yano; F Matsuo; H Saito; T Katagiri; H Kurumizaka; M Yoshimoto; F Kasumi; F Akiyama; G Sakamoto; H Nagawa; Y Nakamura; Y Miki
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

4.  Elevated levels of Rad51 recombination protein in tumor cells.

Authors:  Elke Raderschall; Karen Stout; Susanne Freier; Vanessa Suckow; Susann Schweiger; Thomas Haaf
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

5.  Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.

Authors:  S J Collis; A Tighe; S D Scott; S A Roberts; J H Hendry; G P Margison
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

6.  Domain structure and dynamics in the helical filaments formed by RecA and Rad51 on DNA.

Authors:  X Yu; S A Jacobs; S C West; T Ogawa; E H Egelman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

7.  Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.

Authors:  K Yoshikawa; T Ogawa; R Baer; H Hemmi; K Honda; A Yamauchi; T Inamoto; K Ko; S Yazumi; H Motoda; H Kodama; S Noguchi; A F Gazdar; Y Yamaoka; R Takahashi
Journal:  Int J Cancer       Date:  2000-10-01       Impact factor: 7.396

8.  Autoantibodies in sera of pancreatic cancer patients identify recombination factor Rad51 as a tumour-associated antigen.

Authors:  H Maacke; C Hundertmark; S Miska; M Voss; H Kalthoff; H-W Stürzbecher
Journal:  J Cancer Res Clin Oncol       Date:  2002-02-06       Impact factor: 4.553

9.  Insights into DNA recombination from the structure of a RAD51-BRCA2 complex.

Authors:  Luca Pellegrini; David S Yu; Thomas Lo; Shubha Anand; MiYoung Lee; Tom L Blundell; Ashok R Venkitaraman
Journal:  Nature       Date:  2002-11-10       Impact factor: 49.962

10.  Rad52 protein associates with replication protein A (RPA)-single-stranded DNA to accelerate Rad51-mediated displacement of RPA and presynaptic complex formation.

Authors:  Tomohiko Sugiyama; Stephen C Kowalczykowski
Journal:  J Biol Chem       Date:  2002-06-19       Impact factor: 5.157

View more
  7 in total

Review 1.  RAD51 Gene Family Structure and Function.

Authors:  Braulio Bonilla; Sarah R Hengel; McKenzie K Grundy; Kara A Bernstein
Journal:  Annu Rev Genet       Date:  2020-07-14       Impact factor: 16.830

2.  Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein.

Authors:  Michelle C Silva; Katie E Bryan; Milagros D Morrical; April M Averill; Julie Dragon; Adrian P Wiegmans; Scott W Morrical
Journal:  DNA Repair (Amst)       Date:  2017-10-23

3.  RAD51 interconnects between DNA replication, DNA repair and immunity.

Authors:  Souparno Bhattacharya; Kalayarasan Srinivasan; Salim Abdisalaam; Fengtao Su; Prithvi Raj; Igor Dozmorov; Ritu Mishra; Edward K Wakeland; Subroto Ghose; Shibani Mukherjee; Aroumougame Asaithamby
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

Review 4.  Homologous recombination defects and how they affect replication fork maintenance.

Authors:  Mi Young Son; Paul Hasty
Journal:  AIMS Genet       Date:  2019-04-03

5.  Mut2Vec: distributed representation of cancerous mutations.

Authors:  Sunkyu Kim; Heewon Lee; Keonwoo Kim; Jaewoo Kang
Journal:  BMC Med Genomics       Date:  2018-04-20       Impact factor: 3.063

Review 6.  Variation in RAD51 details a hub of functions: opportunities to advance cancer diagnosis and therapy.

Authors:  Nick Ll van der Zon; Roland Kanaar; Claire Wyman
Journal:  F1000Res       Date:  2018-09-12

7.  Regulation and pharmacological targeting of RAD51 in cancer.

Authors:  McKenzie K Grundy; Ronald J Buckanovich; Kara A Bernstein
Journal:  NAR Cancer       Date:  2020-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.